维普期刊资源整合服务平台（V6.5）

58篇 您的检索式：作者名="Clark CK"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Survival from first recurrence:relative importance of prognostic factors in 1,015 breast cancer patients显示文摘	Clark GM Sledqe GW Jr Osbome CK	1987	J Clin Oncol1987，5，1：	1
2	Improving outcomes after acute coronary syndrome with rehabilitation and secondary prevention显示文摘	Briffa T Chow CK Clark AM	2013	ClinTher2013，35，8：	1
3	Estrogen receptor status by immunohistochemistry is superior to the ligandbinding assay for pre- dicting response to adjuvant endocrine therapy in breast cancer显示文摘	Harvey JM Clark GM Osborne CK	1999	J Clin Oncoi1999，17，5：	1
4	Survival from first re- currence: relative importance of prognostic factors in 1015 breast cancer patients显示文摘	Clark GM Sledge GW Osborne J CK	1987	J Clin Oncol1987，5，：	1
5	Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer显示文摘	Harvey JM Clark GM Osborne CK		0，，05：	1
6	Estrogen receptor status by immunohistochemistry is superior to the llgand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer 显示文摘	Harvey JM Clark GM Osborne CK	1999	J Clin Oncol1999，17，5：	1
7	Estrogen receptor sta- tus by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer显示文摘	Harvey JM Clark GM Osborne CK	1999	J Clin Onco11999，17，5：	1
8	Estrogen receptor status by immunohistochemist, is superior to the ligand - binding assay fir predicting sponse to adjuvant endocrine therapy in breast cancer 显示文摘	Harvey JM Clark GM Osborne CK	1999	J Clin Oucol1999，17，：	1
9	Estrogen receptor status by immunohistochemistry is superior to the ligand bind ing assay for predicling response to adjuvant endocrine therapy in breast cancer显示文摘	Harvey JM Clark GM Osborne CK	1999	J Clin Oncol1999，17，5：	1
10	Estrogen receptor status by immunohistochemistry is superior to the ligand binding assay for predicting response to adjuvant endocrine therapy in breast cancer显示文摘	Harvey JM Clark GM Osborne CK Allred DC	1999	J Clin Oncol1999，17，5：	1
11	Tumor characteris- tics and clinical outcome of tubular and mucinous breast carcinomas显示文摘	Diab SG Clark GM Osborne CK	1999	J Clin Oncol1999，17，5：	1
12	Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer显示文摘	Harvey JM Clark GM Osborne CK	1999	J Clin Oncol1999，17，5：	1
13	Schizophyllum commune:an unusual isolate from a patient with allergic fungal sinusitis显示文摘	Clark S Campbell CK Sandison A	1996	J Infect1996，32，2：	1
14	Estrogen receptor status by immunohistochemistry is superior to the ligand-hinding assay for predicting response to adjuvant endocrine therapy in breast cancer 显示文摘	Harvey J Clark GM Osborne CK	1999	J Clin Oncol1999，17，：	1
15	Vesicalleucoplakia 显示文摘	DeKock ML Clark PB Anderson CK	1980	S Afr Med J1980，58，18：	1
16	Estrogen receptor sta- tus by immunohistochemistry is superior to the ligand-blnding assay for predicting response to adjuvant endocrine therapy in breast cancer显示文摘	Harvey JM Clark GM Osborne CK	1999	J CIin Oncal1999，17，5：	1
17	Estrogen receptor status by immunohistochemistry is superior to the ligand - binding assay for predicting response to adjuvant endocrine therapy in breast cancer显示文摘	Harvey JM Clark GM Osborne CK	1999	J Clin Oncol1999，17，：	1
18	Tumor characteris- tics and clinical outcome of tubular breast carcinomas 显示文摘	Diab SG Clark GM Osborne CK	1999	J Clin 0ncol1999，17，5：	1
19	Estrogen receptor status by immu-nohistochemistry is superior to the ligandbinding assay for predicting response to adjuvant endocrine therapy in breast cancer显示文摘	Harvey JM Clark GM Osborne CK	1999	J Clin Oncol1999，17，：	1
20	Kinematics of the cervical spine following discetomy and stabilization显示文摘	Schulte K Clark CK Goel VK	1998	Spine1998，14，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示